{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:27Z","timestamp":1792783407057,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12098-016-2058-6","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T20:17:08Z","timestamp":1456863428000},"page":"1311-1320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Child with Jaundice and Pruritus: How to Evaluate?"],"prefix":"10.1007","volume":"83","author":[{"given":"Barath","family":"Jagadisan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshu","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"2058_CR1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237\u201367.","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"2058_CR2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.26909","volume":"60","author":"U Beuers","year":"2014","unstructured":"Beuers U, Kremer AE, Bolier R, Elferink RP. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60:399\u2013407.","journal-title":"Hepatology"},{"key":"2058_CR3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","volume":"68","author":"AE Kremer","year":"2008","unstructured":"Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163\u201382.","journal-title":"Drugs"},{"key":"2058_CR4","doi-asserted-by":"crossref","unstructured":"Samanta T, Das AK, Ganguly S. Profile of hepatitis A infection with atypical manifestations in children. Indian J Gastroenterol. 2010;29:31\u20133.","DOI":"10.1007\/s12664-010-8003-0"},{"key":"2058_CR5","doi-asserted-by":"crossref","unstructured":"Saboo AR, Vijaykumar R, Save SU, Bavdekar SB. Prolonged cholestasis following hepatitis A virus infection: revisiting the role of steroids. J Global Infect Dis. 2012;4:185\u20136.","DOI":"10.4103\/0974-777X.100588"},{"key":"2058_CR6","doi-asserted-by":"crossref","unstructured":"Ertekin V, Selimo\u011flu MA, Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei Med J. 2003;44:939\u201342.","DOI":"10.3349\/ymj.2003.44.5.939"},{"key":"2058_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","volume":"4","author":"A Srivastava","year":"2014","unstructured":"Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4:25\u201336.","journal-title":"J Clin Exp Hepatol"},{"key":"2058_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPG.0b013e3181596060","volume":"46","author":"FT Alissa","year":"2008","unstructured":"Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2008;46:241\u201352.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MPG.0b013e3181cea48d","volume":"50","author":"BM Kamath","year":"2010","unstructured":"Kamath BM, Munoz PS, Bab N, et al. A longitudinal study to identify laboratory predictors of liver disease outcome in alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;50:526\u201330.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12664-013-0392-4","volume":"33","author":"A Srivastava","year":"2014","unstructured":"Srivastava A, Goel D, Bolia R, Poddar U, Yachha SK. Alagille syndrome: experience of a tertiary care center in north India. Indian J Gastroenterol. 2014;33:59\u201362.","journal-title":"Indian J Gastroenterol"},{"key":"2058_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2007-985076","volume":"27","author":"J Sinha","year":"2007","unstructured":"Sinha J, Magid MS, VanHuse C, Thung SN, Suchy F, Kerkar N. Bile duct paucity in infancy. Semin Liver Dis. 2007;27:319\u201323.","journal-title":"Semin Liver Dis"},{"key":"2058_CR12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011;53:1377\u201387.","journal-title":"Hepatology"},{"key":"2058_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11894-010-0104-5","volume":"12","author":"N Kerkar","year":"2010","unstructured":"Kerkar N, Miloh T. Sclerosing cholangitis: pediatric perspective. Curr Gastroenterol Rep. 2010;12:195\u2013202.","journal-title":"Curr Gastroenterol Rep"},{"key":"2058_CR14","doi-asserted-by":"crossref","unstructured":"Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E; Studies of Pediatric Liver Transplantation Research Group. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl. 2011;17:925\u201333.","DOI":"10.1002\/lt.22320"},{"key":"2058_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","volume":"7","author":"T Miloh","year":"2009","unstructured":"Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009;7:239\u201345.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2058_CR16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s13312-010-0174-3","volume":"47","author":"NK Arora","year":"2010","unstructured":"Arora NK, Arora S, Ahuja A, et al. Alpha 1 antitrypsin deficiency in children with chronic liver disease in north India. Indian Pediatr. 2010;47:1015\u201323.","journal-title":"Indian Pediatr"},{"key":"2058_CR17","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","volume":"294","author":"T Sveger","year":"1976","unstructured":"Sveger T. Liver disease in \u03b11-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294:1316\u201321.","journal-title":"N Engl J Med"},{"key":"2058_CR18","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","volume":"10","author":"D Debray","year":"2011","unstructured":"Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10:S29\u201336.","journal-title":"J Cyst Fibros"},{"key":"2058_CR19","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/01.mpg.0000226390.02355.52","volume":"43","author":"C Colombo","year":"2006","unstructured":"Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43:S49\u201355.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e3181b47b34","volume":"50","author":"P Subramaniam","year":"2010","unstructured":"Subramaniam P, Clayton PT, Portmann BC, Mieli-Vergani G, Hadzi\u0107 N. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr. 2010;50:61\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/adc.2010.195974","volume":"97","author":"E Makin","year":"2012","unstructured":"Makin E, Davenport M. Understanding choledochal malformation. Arch Dis Child. 2012;97:69\u201372.","journal-title":"Arch Dis Child"},{"key":"2058_CR22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1478-3231.2011.02668.x","volume":"32","author":"T Kumagi","year":"2012","unstructured":"Kumagi T, Drenth JP, Guttman O, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int. 2012;32:510\u20138.","journal-title":"Liver Int"},{"key":"2058_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00383-007-2087-3","volume":"24","author":"RP Krishna","year":"2008","unstructured":"Krishna RP, Lal R, Sikora SS, Yachha SK, Pal L. Unusual causes of extrahepatic biliary obstruction in children: a case series with review of literature. Pediatr Surg Int. 2008;24:183\u201390.","journal-title":"Pediatr Surg Int"},{"key":"2058_CR24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1072-7515(00)00725-0","volume":"191","author":"JP Pryor","year":"2000","unstructured":"Pryor JP, Volpe CM, Caty MG, Doerr RJ. Noncalculous biliary obstruction in the child and adolescent. J Am Coll Surg. 2000;191:569\u201378.","journal-title":"J Am Coll Surg"},{"key":"2058_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1089-3261(03)00135-1","volume":"8","author":"G Paumgartner","year":"2004","unstructured":"Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004;8:67\u201381.","journal-title":"Clin Liver Dis"},{"key":"2058_CR26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009;50:808\u201314.","journal-title":"Hepatology"},{"key":"2058_CR27","doi-asserted-by":"crossref","unstructured":"Chapman R, Fevery J, Kalloo A, et al; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u201378.","DOI":"10.1002\/hep.23294"},{"key":"2058_CR28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00005176-199705000-00016","volume":"24","author":"WF Balistreri","year":"1997","unstructured":"Balistreri WF. Bile acid therapy in pediatric Hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997;24:573\u201389.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","volume":"25","author":"E Jacquemin","year":"1997","unstructured":"Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 1997;25:519\u201323.","journal-title":"Hepatology"},{"key":"2058_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","volume":"50","author":"DV Datta","year":"1966","unstructured":"Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50:323\u201332.","journal-title":"Gastroenterology"},{"key":"2058_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12098-007-0044-8","volume":"74","author":"H El-Karaksy","year":"2007","unstructured":"El-Karaksy H, Mansour S, El-Sayed R, El-Raziky M, El-Koofy N, Taha G. Safety and efficacy of rifampicin in children with cholestatic pruritus. Indian J Pediatr. 2007;74:279\u201381.","journal-title":"Indian J Pediatr"},{"key":"2058_CR32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0016-5085(90)90027-X","volume":"98","author":"HA Cynamon","year":"1990","unstructured":"Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990;98:1013\u20136.","journal-title":"Gastroenterology"},{"key":"2058_CR33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","volume":"102","author":"NV Bergasa","year":"1992","unstructured":"Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 1992;102:544\u20139.","journal-title":"Gastroenterology"},{"key":"2058_CR34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/MPG.0b013e3181eb5ac0","volume":"51","author":"A Zellos","year":"2010","unstructured":"Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr. 2010;51:787\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","volume":"10","author":"C M\u00fcller","year":"1998","unstructured":"M\u00fcller C, Pongratz S, Pidlich J, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol. 1998;10:865\u201370.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2058_CR36","doi-asserted-by":"crossref","unstructured":"Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with Alagille syndrome: the King\u2019s college hospital experience. J Pediatr Gastroenterol Nutr. 2013;57:149\u201354.","DOI":"10.1097\/MPG.0b013e318297e384"},{"key":"2058_CR37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02430.x","volume":"21","author":"JW O\u2019Donohue","year":"2005","unstructured":"O\u2019Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R. A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther. 2005;21:1041\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"2058_CR38","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.transproceed.2006.08.052","volume":"38","author":"JL Montero","year":"2006","unstructured":"Montero JL, Pozo JC, Barrera P, et al. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Transplant Proc. 2006;38:2511\u20133.","journal-title":"Transplant Proc"},{"key":"2058_CR39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00005176-200002000-00011","volume":"30","author":"VL Ng","year":"2000","unstructured":"Ng VL, Ryckman FC, Porta G, et al. Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 2000;30:152\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2058_CR40","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.pcl.2009.06.005","volume":"56","author":"S Nightingale","year":"2009","unstructured":"Nightingale S, Lee NV. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin N Am. 2009;56:1161\u201383.","journal-title":"Pediatr Clin N Am"},{"key":"2058_CR41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cld.2012.12.005","volume":"17","author":"AF Carrion","year":"2013","unstructured":"Carrion AF, Bhamidimarri KR. Liver transplant for cholestatic liver diseases. Clin Liver Dis. 2013;17:345\u201359.","journal-title":"Clin Liver Dis"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-016-2058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-016-2058-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-016-2058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-016-2058-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:25:01Z","timestamp":1718375101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-016-2058-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1007\/s12098-016-2058-6","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}